FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079448135> ?p ?o ?g. }

• W2079448135 endingPage "e84" @default.
• W2079448135 startingPage "312" @default.
• W2079448135 abstract "BACKGROUND Linaclotide is a novel, orally administered investigational drug currently in clinical development for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic idiopathic constipation. Visceral hyperalgesia is a major pathophysiological mechanism in IBS-C. Therefore, we investigated the anti-nociceptive properties of linaclotide in rodent models of inflammatory and non-inflammatory visceral pain and determined whether these pharmacological effects are linked to the activation of guanylate cyclase C (GC-C). METHODS Orally administered linaclotide was evaluated in non-inflammatory acute partial restraint stress (PRS) and acute water avoidance stress (WAS) models in Wistar rats, and in a trinitrobenzene sulfonic acid (TNBS)-induced inflammatory model in Wistar rats and GC-C null mice. KEY RESULTS In TNBS-induced colonic allodynia, linaclotide significantly decreased the number of abdominal contractions in response to colorectal distension without affecting the colonic wall elasticity change in response to distending pressures after TNBS. However, linaclotide had no effect on visceral sensitivity under basal conditions. In addition, linaclotide significantly decreased colonic hypersensitivity in the PRS and WAS models. In wild type (wt) and GC-C null mice, the instillation of TNBS induced similar hyperalgesia and allodynia. However, in post-inflammatory conditions linaclotide significantly reduced hypersensitivity only in wt mice, but not in GC-C null mice. CONCLUSIONS & INFERENCES These findings indicate that linaclotide has potent anti-nociceptive effects in several mechanistically different rodent models of visceral hypersensitivity and that these pharmacological properties of linaclotide are exerted through the activation of the GC-C receptor. Therefore, linaclotide may be capable of decreasing abdominal pain in patients suffering from IBS-C." @default.
• W2079448135 created "2016-06-24" @default.
• W2079448135 creator A5001446657 @default.
• W2079448135 creator A5015148992 @default.
• W2079448135 creator A5019918179 @default.
• W2079448135 creator A5023288534 @default.
• W2079448135 creator A5030343626 @default.
• W2079448135 creator A5040188832 @default.
• W2079448135 creator A5040496380 @default.
• W2079448135 creator A5053117866 @default.
• W2079448135 creator A5068196876 @default.
• W2079448135 creator A5086224587 @default.
• W2079448135 creator A5087337307 @default.
• W2079448135 creator A5088270231 @default.
• W2079448135 creator A5090467039 @default.
• W2079448135 date "2010-03-01" @default.
• W2079448135 modified "2023-10-15" @default.
• W2079448135 title "Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain" @default.
• W2079448135 cites W1580767903 @default.
• W2079448135 cites W1588618357 @default.
• W2079448135 cites W1951147698 @default.
• W2079448135 cites W1965194352 @default.
• W2079448135 cites W1966720579 @default.
• W2079448135 cites W1973915683 @default.
• W2079448135 cites W1976351465 @default.
• W2079448135 cites W1980588138 @default.
• W2079448135 cites W1992000894 @default.
• W2079448135 cites W1992726845 @default.
• W2079448135 cites W1998904527 @default.
• W2079448135 cites W2003544081 @default.
• W2079448135 cites W2010176684 @default.
• W2079448135 cites W2011072311 @default.
• W2079448135 cites W2018187920 @default.
• W2079448135 cites W2035308268 @default.
• W2079448135 cites W2036895238 @default.
• W2079448135 cites W2037284544 @default.
• W2079448135 cites W2044044822 @default.
• W2079448135 cites W2056129681 @default.
• W2079448135 cites W2057212992 @default.
• W2079448135 cites W2065349462 @default.
• W2079448135 cites W2070981527 @default.
• W2079448135 cites W2072498988 @default.
• W2079448135 cites W2074762600 @default.
• W2079448135 cites W2090144284 @default.
• W2079448135 cites W2092250377 @default.
• W2079448135 cites W2121619203 @default.
• W2079448135 cites W212251127 @default.
• W2079448135 cites W2124063036 @default.
• W2079448135 cites W2127671305 @default.
• W2079448135 cites W2130086849 @default.
• W2079448135 cites W2130371445 @default.
• W2079448135 cites W2132122176 @default.
• W2079448135 cites W2139551702 @default.
• W2079448135 cites W2153312234 @default.
• W2079448135 cites W2158148601 @default.
• W2079448135 cites W2160919674 @default.
• W2079448135 cites W2161238054 @default.
• W2079448135 cites W2161753896 @default.
• W2079448135 cites W2294522417 @default.
• W2079448135 doi "https://doi.org/10.1111/j.1365-2982.2009.01385.x" @default.
• W2079448135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19706070" @default.
• W2079448135 hasPublicationYear "2010" @default.
• W2079448135 type Work @default.
• W2079448135 sameAs 2079448135 @default.
• W2079448135 citedByCount "161" @default.
• W2079448135 countsByYear W20794481352012 @default.
• W2079448135 countsByYear W20794481352013 @default.
• W2079448135 countsByYear W20794481352014 @default.
• W2079448135 countsByYear W20794481352015 @default.
• W2079448135 countsByYear W20794481352016 @default.
• W2079448135 countsByYear W20794481352017 @default.
• W2079448135 countsByYear W20794481352018 @default.
• W2079448135 countsByYear W20794481352019 @default.
• W2079448135 countsByYear W20794481352020 @default.
• W2079448135 countsByYear W20794481352021 @default.
• W2079448135 countsByYear W20794481352022 @default.
• W2079448135 countsByYear W20794481352023 @default.
• W2079448135 crossrefType "journal-article" @default.
• W2079448135 hasAuthorship W2079448135A5001446657 @default.
• W2079448135 hasAuthorship W2079448135A5015148992 @default.
• W2079448135 hasAuthorship W2079448135A5019918179 @default.
• W2079448135 hasAuthorship W2079448135A5023288534 @default.
• W2079448135 hasAuthorship W2079448135A5030343626 @default.
• W2079448135 hasAuthorship W2079448135A5040188832 @default.
• W2079448135 hasAuthorship W2079448135A5040496380 @default.
• W2079448135 hasAuthorship W2079448135A5053117866 @default.
• W2079448135 hasAuthorship W2079448135A5068196876 @default.
• W2079448135 hasAuthorship W2079448135A5086224587 @default.
• W2079448135 hasAuthorship W2079448135A5087337307 @default.
• W2079448135 hasAuthorship W2079448135A5088270231 @default.
• W2079448135 hasAuthorship W2079448135A5090467039 @default.
• W2079448135 hasConcept C126322002 @default.
• W2079448135 hasConcept C15490471 @default.
• W2079448135 hasConcept C170493617 @default.
• W2079448135 hasConcept C2778271842 @default.
• W2079448135 hasConcept C2779245659 @default.
• W2079448135 hasConcept C2779794527 @default.
• W2079448135 hasConcept C71924100 @default.

• next